Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 206111

Expand all

SYNJARDY (EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE)
5MG;500MG
Marketing Status: Prescription

Active Ingredient: EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Proprietary Name: SYNJARDY
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG;500MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N206111
Product Number: 001
Approval Date: Aug 26, 2015
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

SYNJARDY (EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE)
5MG;1GM
Marketing Status: Prescription

Active Ingredient: EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Proprietary Name: SYNJARDY
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG;1GM
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N206111
Product Number: 002
Approval Date: Aug 26, 2015
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

SYNJARDY (EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE)
12.5MG;500MG
Marketing Status: Prescription

Active Ingredient: EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Proprietary Name: SYNJARDY
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;500MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N206111
Product Number: 003
Approval Date: Aug 26, 2015
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

SYNJARDY (EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE)
12.5MG;1GM
Marketing Status: Prescription

Active Ingredient: EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Proprietary Name: SYNJARDY
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;1GM
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N206111
Product Number: 004
Approval Date: Aug 26, 2015
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information